论文部分内容阅读
目的 :评价彩超联合钼靶在乳腺筛查中的价值。方法 :2016年1月~2016年12月,医院体检中心与门诊开展乳腺疾病筛查4028次,根据超声以及钼靶检查结果,决定是否需要活检手术或随访。结果 :超声检出异常率12.69%(511/4028),钼靶检出异常率18.42%(742/4028),两者联合检出病灶20.90%(842/4028)差异有统计学意义(P<0.05)。114例患者进行活检以及手术病理诊断证实,联合检查特异性、阴性预测值、符合率高于钼靶检查,差异有统计学意义(P<0.05)。结论 :彩超、钼靶乳腺疾病筛查诊断中各有优劣,钼靶病灶检出率更高而彩超检查可避免误诊,两者联合有助于检出更多的病灶。
Objective: To evaluate the value of combined ultrasonography and mammography in breast screening. Methods: From January 2016 to December 2016, the hospital physical examination center and outpatient clinic carried out 4028 breast disease screening. According to the results of ultrasound and mammography examination, it was decided whether biopsy operation or follow-up was needed. Results: The abnormal rate of ultrasonography was 12.69% (511/4028) and the abnormal rate of molybdenum target detection was 18.42% (742/4028). The difference of 20.90% (842/4028) between the two methods was statistically significant (P < 0.05). The biopsy and pathological diagnosis of 114 patients confirmed that the combined detection of specificity and negative predictive value was higher than that of mammography, the difference was statistically significant (P <0.05). Conclusion: The results of color Doppler ultrasound and mammography screening have their advantages and disadvantages, the detection rate of Molybdenum target lesions is higher and color Doppler ultrasound examination can avoid the misdiagnosis. The combination of the two can help detect more lesions.